Immunovia AB (publ) (IMMVF)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.57 Million | 1.14 Million | 844 Thousand | 362 Thousand | 356 Thousand | 333 Thousand |
| Cost of Revenue | 6.68 Million | 4.21 Million | -14.96 Million | -40.02 Million | -26.71 Million | -25.05 Million |
| Gross Profit | -5.1 Million | -3.06 Million | 15.81 Million | 40.38 Million | 27.07 Million | 25.38 Million |
| Operating Expenses | 291.5 Million | 188.14 Million | 182.55 Million | 175.06 Million | 141.42 Million | 113.61 Million |
| Selling, General and Administrative Expenses | 182.87 Million | -4.57 Million | 82.6 Million | 91.14 Million | 78.32 Million | 65.27 Million |
| Research and Development Expenses | - | 4.57 Million | 4.73 Million | 5.85 Million | 3.65 Million | 2.93 Million |
| Other Expenses | 108.63 Million | - | - | - | - | 221.22 Thousand |
| Cost and Expenses | 298.03 Million | 192.35 Million | 167.58 Million | 135.04 Million | 114.7 Million | 88.56 Million |
| Operating Income | -296.46 Million | -191.15 Million | -166.62 Million | -134.34 Million | -114.24 Million | -87.7 Million |
| Interest Expense | 1.16 Million | 1.6 Million | 1.43 Million | 1.41 Million | 1.31 Million | 1000.00 |
| Income Tax Expense | - | 3.71 Million | 2.38 Million | -56.93 Thousand | 4000.00 | 7000.00 |
| Earnings before Tax | -309.43 Million | -168.09 Million | -155.96 Million | -146.03 Million | -114.51 Million | -86.53 Million |
| Net Income | -309.43 Million | -168.09 Million | -155.96 Million | -146.03 Million | -114.52 Million | -86.53 Million |
| Earnings Per Share Basic | -7.95 | -6.89 | -6.40 | -6.35 | -5.43 | -4.33 |
| Earnings Per Share Diluted | -7.95 | -6.89 | -6.40 | -6.35 | -5.43 | -4.33 |
| Weighted Average Shares Outstanding | 38.92 Million | 24.38 Million | 24.38 Million | 22.99 Million | 21.08 Million | 19.98 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.93 Million | 24.38 Million | 24.38 Million | 22.99 Million | 21.08 Million | 19.98 Million |
| Gross Margin | -3.24 | -2.68 | 18.74 | 111.55 | 76.04 | 76.23 |
| EBIT Margin | -105.75 | -123.65 | -160.51 | -372.52 | -294.25 | -251.51 |
| Profit Margin | -196.47 | -146.81 | -184.79 | -403.41 | -321.69 | -259.88 |
| EBITDA | -166.55 Million | -141.57 Million | -135.47 Million | -134.85 Million | -104.75 Million | -85.45 Million |
| Earnings Before Tax Margin | -188.23 | -166.94 | -197.43 | -371.11 | -320.92 | -263.39 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 85 Thousand | 156 Thousand | 156 Thousand | 1.57 Million | 488 Thousand | 412 Thousand |
| Cost of Revenue | 24.05 Million | - | 22.47 Million | 6.68 Million | 144 Thousand | 5.5 Million |
| Gross Profit | -23.97 Million | 156 Thousand | -22.31 Million | -5.1 Million | 344 Thousand | -5.08 Million |
| Operating Expenses | 23.99 Million | 24.31 Million | 23.71 Million | 291.5 Million | 39.23 Million | 179.99 Million |
| Selling, General and Administrative Expenses | -5.31 Million | 21.74 Million | 20.03 Million | - | -612.4 Thousand | -760.92 Thousand |
| Research and Development Expenses | 5.31 Million | 6.55 Million | 4.09 Million | - | 612.4 Thousand | 760.92 Thousand |
| Other Expenses | -3.78 Million | - | - | - | - | - |
| Cost and Expenses | 24.05 Million | 24.31 Million | 23.71 Million | 298.19 Million | 39.37 Million | 185.49 Million |
| Operating Income | -23.97 Million | -24.15 Million | -23.4 Million | -296.46 Million | -38.88 Million | -185.07 Million |
| Interest Expense | 1.69 Million | 147 Thousand | -3.12 Million | 1.16 Million | 635 Thousand | 647 Thousand |
| Income Tax Expense | - | 21.35 Million | -28.68 Million | -11.58 Million | 580 Thousand | 578.69 Thousand |
| Earnings before Tax | -25.59 Million | -2.94 Million | -49.02 Million | -309.43 Million | -38.55 Million | -170.2 Million |
| Net Income | -25.59 Million | -2.94 Million | -49.02 Million | -309.43 Million | -38.55 Million | -170.2 Million |
| Earnings Per Share Basic | -0.28 | -0.07 | -1.08 | - | -0.91 | -4.00 |
| Earnings Per Share Diluted | -0.28 | -0.07 | -1.08 | - | -0.91 | -4.00 |
| Weighted Average Shares Outstanding | 91.16 Million | 45.28 Million | 45.28 Million | 41.94 Million | 42.51 Million | 42.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 91.16 Million | 45.28 Million | 45.28 Million | 41.94 Million | 42.51 Million | 42.51 Million |
| Gross Margin | -282.04 | 1.00 | -143.05 | -3.24 | 0.70 | -12.35 |
| EBIT Margin | -263.25 | 1.16 | -318.65 | - | -72.59 | -94.29 |
| Profit Margin | -301.14 | -18.88 | -314.23 | -196.47 | -79.01 | -413.12 |
| EBITDA | -22.37 Million | 181 Thousand | -49.71 Million | - | -35.42 Million | -38.84 Million |
| Earnings Before Tax Margin | -282.04 | -154.85 | -150.04 | -188.23 | -79.69 | -449.21 |
WNBD
SOZAP
0SOM
SSOK
PVA
NVENTURES